Poolbeg Pharma Plc
Scientific Advisory Board's Endorsement Boosts Credibility of AI-Led Influenza Drug Discovery Program
By Elric Langton and Alex Langton | 26 October 2023
I have a financial interest in Poolbeg Pharma
Poolbeg Pharma, a forward-thinking clinical-stage biopharmaceutical company dedicated to addressing diseases with a significant unmet medical need, announced its Scientific Advisory Board (SAB) has endorsed the influenza drug targets uncovered through Poolbeg’s innovative AI-driven drug discovery program. Of course, the bullet board experts seem to have ignored critical aspects of today’s announcement, instead focussing on the fact that the Company’s in-house SAB endorsed the identified influenza drug targets. I will come back to this later.